Butterfly Network launches iQ+ and iQ3 handheld ultrasound in Brazil

Zacks Investment Research··Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Butterfly Network has commercially launched its Butterfly iQ+ and iQ3 handheld ultrasound devices and mobile application in Brazil through authorized distribution partners. The launch expands the company's international presence into Latin America's largest medical device market, where demand for portable diagnostic solutions is growing. Management noted that meeting Brazil's rigorous regulatory standards underscores the strength of its Ultrasound-on-Chip technology. The devices, already sold in the U.S. and multiple international regions, contributed to a 23% year-over-year increase in international revenues in the first quarter of 2026. Despite the announcement, Butterfly Network shares fell 3.2% on the day, though the stock has risen 102.1% year to date.

Impact on assets 4

Health Care▲
Butterfly Network Inc
BFLY
▲ PositiveDemandrelevance

Commercial launch in Brazil expands market reach and international revenue growth.

Robotics & Physical AI▲
Biotech & Genomic Medicine▲